Toll Free: 1-888-928-9744

Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014', provides an overview of the Amorfix Life Sciences Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Amorfix Life Sciences Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Amorfix Life Sciences Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Amorfix Life Sciences Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Amorfix Life Sciences Ltd.'s pipeline products

Reasons to buy

- Evaluate Amorfix Life Sciences Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Amorfix Life Sciences Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Amorfix Life Sciences Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Amorfix Life Sciences Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Amorfix Life Sciences Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Amorfix Life Sciences Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Amorfix Life Sciences Ltd. Snapshot 4
Amorfix Life Sciences Ltd. Overview 4
Key Information 4
Key Facts 4
Amorfix Life Sciences Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
Amorfix Life Sciences Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Amorfix Life Sciences Ltd. - Pipeline Products Glance 12
Amorfix Life Sciences Ltd. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Amorfix Life Sciences Ltd. - Drug Profiles 14
ALS Therapeutic Vaccine 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
AMF-1c120 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
AMF-3d19 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Antibodies for Cancer 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Next Generation Monoclonal Antibody to Inhibit CD38 for cancer 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Amorfix Life Sciences Ltd. - Pipeline Analysis 21
Amorfix Life Sciences Ltd. - Pipeline Products by Target 21
Amorfix Life Sciences Ltd. - Pipeline Products by Molecule Type 22
Amorfix Life Sciences Ltd. - Pipeline Products by Mechanism of Action 23
Amorfix Life Sciences Ltd. - Recent Pipeline Updates 24
Amorfix Life Sciences Ltd. - Company Statement 26
Amorfix Life Sciences Ltd. - Locations And Subsidiaries 28
Head Office 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30
List of Tables
Amorfix Life Sciences Ltd., Key Information 4
Amorfix Life Sciences Ltd., Key Facts 4
Amorfix Life Sciences Ltd. - Pipeline by Indication, 2014 7
Amorfix Life Sciences Ltd. - Pipeline by Stage of Development, 2014 8
Amorfix Life Sciences Ltd. - Monotherapy Products in Pipeline, 2014 9
Amorfix Life Sciences Ltd. - Out-Licensed Products in Pipeline, 2014 10
Amorfix Life Sciences Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2014 11
Amorfix Life Sciences Ltd. - Preclinical, 2014 12
Amorfix Life Sciences Ltd. - Discovery, 2014 13
Amorfix Life Sciences Ltd. - Pipeline by Target, 2014 21
Amorfix Life Sciences Ltd. - Pipeline by Molecule Type, 2014 22
Amorfix Life Sciences Ltd. - Pipeline Products by Mechanism of Action, 2014 23
Amorfix Life Sciences Ltd. - Recent Pipeline Updates, 2014 24 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify